thinkstockOctober 16, 2014: Markets opened lower on Thursday following a sharp drop in crude oil prices overnight and a better-than-expected report on new claims for jobless benefits. St. Louis Fed President James…
Short sellers have decided to get out of some of the go-to defensive stocks with high-dividend yields in late September.
With or without mid-term elections, the last quarter of 2014 and January of next year could be a bonanza for stock investors.
24/7 Wall St. has tracked several defensive stocks that are not down near as much as the market on Thursday.
24/7 Wall St. takes look at what is happening in the short interest of the go-to high-dividend defensive stocks.
The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late.
thinkstockSeptember 17, 2014: Markets opened slightly mixed on Wednesday and traded in a narrow range around the break-even line until the FOMC meeting announcement in mid-afternoon. The word that interest rates would…
thinkstockSeptember 15, 2014: Markets opened slightly lower on Monday after the OECD lowered its U.S. GDP growth forecast. The Empire State manufacturing index rose sharply in September. That rise was offset somewhat…
The short interest data for the August 29 settlement date is out, and we have decided to look at what is happening in the short interest of the go-to high-dividend defensive stocks.
A great deal was made of the value of Facebook as it crossed the $200 billion market cap level. There is a powerful argument that Facebook is too expensive.
4/7 Wall St. reviews short interest in the higher-yield defensive dividend stocks for a sense of what short sellers may be thinking.
thinkstockAugust 26, 2014: Markets opened higher on Tuesday following a huge jump in durable goods orders, a better-than-expected report on consumer confidence, and a slowdown in home price increases. The DJIA hit…
ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had approved the drug ELIQUIS, as a treatment for Deep Vein Thrombosis and Pulmonary Embolisms. Each…
Investors seem to have grown accustomed to seeing the Dow Jones Industrial Average (DJIA) hitting new high after new high in 2014. Only the recent market volatility has created a situation where…
thinkstockAugust 14, 2014: Markets opened higher on Thursday after a slightly worse-than-expected report on new claims for unemployment benefits. U.S. export prices were higher in July and natural gas prices rose about…
